Gary M. Owens
Net Worth
Last updated:
What is Gary M. Owens net worth?
The estimated net worth of Mr. Gary M. Owens is at least $11,467,228 as of 29 Oct 2024. He owns shares worth $3,042,691 as insider, has earned $3,217,657 from insider trading and has received compensation worth at least $5,206,880 in Mesa Laboratories, Inc..
What is the salary of Gary M. Owens?
Mr. Gary M. Owens salary is $743,840 per year as Chief Executive Officer, Pres & Director in Mesa Laboratories, Inc..
How old is Gary M. Owens?
Mr. Gary M. Owens is 57 years old, born in 1968.
What stocks does Gary M. Owens currently own?
As insider, Mr. Gary M. Owens owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Mesa Laboratories, Inc. (MLAB) | Chief Executive Officer, Pres & Director | 43,337 | $70.21 | $3,042,691 |
What does Mesa Laboratories, Inc. do?
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Gary M. Owens insider trading
Mesa Laboratories, Inc.
Mr. Gary M. Owens has made 10 insider trades between 2018-2024, according to the Form 4 filled with the SEC. Most recently he sold 2,551 units of MLAB stock worth $285,651 on 29 Oct 2024.
The largest trade he's ever made was exercising 6,545 units of MLAB stock on 16 Jun 2021. As of 29 Oct 2024 he still owns at least 43,337 units of MLAB stock.
Mesa Laboratories key executives
Mesa Laboratories, Inc. executives and other stock owners filed with the SEC:
- Mr. Brian David Archbold (50) Senior Vice President of Continuous Improvement & Operations
- Mr. Gary M. Owens (57) Chief Executive Officer, Pres & Director
- Mr. Gregory T. DiNoia (60) Senior Vice President of Commercial Operations
- Mr. John V. Sakys (56) Chief Financial Officer & Chief Accounting Officer